Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.
- DOI
- 10.3390/jcm15145558
- Published
- 2026 Jul 15
- Container
- Journal of clinical medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/jcm15145558,
title = {Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.},
author = {Chernova P and Orlova M and Baryakh E and Misyurina E and Tolstykh T and Zotina E and Tyshkevich G and Basova V and Suvorina M and Misyurin A and Mingalimov M},
year = {2026},
journal = {Journal of clinical medicine},
doi = {10.3390/jcm15145558},
url = {https://doi.org/10.3390/jcm15145558}
}RIS
TY - JOUR TI - Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review. AU - Chernova P AU - Orlova M AU - Baryakh E AU - Misyurina E AU - Tolstykh T AU - Zotina E AU - Tyshkevich G AU - Basova V AU - Suvorina M AU - Misyurin A AU - Mingalimov M PY - 2026 JO - Journal of clinical medicine DO - 10.3390/jcm15145558 UR - https://doi.org/10.3390/jcm15145558 ER -
APA
P, C., M, O., E, B., E, M., T, T., E, Z., G, T., V, B., M, S., A, M., & M, M. (2026). Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.. Journal of clinical medicine. https://doi.org/10.3390/jcm15145558
Source records
- pubmed · retrieved 2026-09-26T09:12:46.616Z